Cover Image

Galectin-3 reflects mitral annular plane systolic excursion being assessed by cardiovascular magnetic resonance imaging

Background. This study investigates whether serum levels of galectin-3 may reflect impaired mitral annular plane systolic excursion (MAPSE) in patients undergoing cardiac magnetic resonance imaging (cMRI). Methods. Patients undergoing cMRI during routine clinical care were included prospectively wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, Seung‑Hyun (Author) , Behnes, Michael (Author) , Natale, Michèle (Author) , Hoffmann, Julia (Author) , Reckord, Nadine (Author) , Hoffmann, Ursula (Author) , Budjan, Johannes (Author) , Henzler, Thomas (Author) , Papavassiliu, Theano (Author) , Borggrefe, Martin (Author) , Akın, Ibrahim (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: Disease markers
Year: 2016, Volume: 2016, Issue: $t9
ISSN:1875-8630
DOI:10.1155/2016/7402784
Online Access:Verlag, Volltext: http://dx.doi.org/10.1155/2016/7402784
Verlag, Volltext: https://www.hindawi.com/journals/dm/2016/7402784/
Get full text
Author Notes:Seung-Hyun Kim, Michael Behnes, Michele Natale, Julia Hoffmann, Nadine Reckord, Ursula Hoffmann, Johannes Budjan, Thomas Henzler, Theano Papavassiliu, Martin Borggrefe, Thomas Bertsch, and Ibrahim Akin
Description
Summary:Background. This study investigates whether serum levels of galectin-3 may reflect impaired mitral annular plane systolic excursion (MAPSE) in patients undergoing cardiac magnetic resonance imaging (cMRI). Methods. Patients undergoing cMRI during routine clinical care were included prospectively within an all-comers design. Blood samples for biomarker measurements were collected within 24 hours following cMRI. Statistical analyses were performed in all patients and in three subgroups according to MAPSE (MAPSE I: ≥11 mm, MAPSE II: ≥8 mm-<11 mm, and MAPSE III: <8 mm). Patients with right ventricular dysfunction (<50%) were excluded. Results. 84 patients were included in the study. Median LVEF was 59% (IQR 51-64%). Galectin-3 correlated significantly with NT-proBNP (, ). Galectin-3 increased significantly according to the different stages of impaired MAPSE () and was able to discriminate both patients with impaired MAPSE <11 mm (area under the curve (AUC) = 0.645, ) and <8 mm (AUC = 0.733, ). Combining galectin-3 with NT-proBNP improved discrimination of MAPSE <8 mm (AUC 0.803, ). In multivariable logistic regression models galectin-3 was still associated with impaired MAPSE (MAPSE < 11 mm: odds ratio (OR) = 3.53, ; MAPSE < 8 mm: OR = 3.18, ). Conclusions. Galectin-3 reflects MAPSE being assessed by cardiac MRI.
Item Description:Gesehen am 07.02.2019
Physical Description:Online Resource
ISSN:1875-8630
DOI:10.1155/2016/7402784

Similar Items